Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer [Phase 2]
A Phase 2 trial evaluating gemcitabine hydrochloride and cisplatin before surgery in patients with muscle invasive bladder cancer was termin…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Perioperative Oral Nutrition Intervention for Patients Undergoing Radical Cystectomy [NA]
The document reports completion of a clinical trial evaluating perioperative oral nutrition intervention for bladder cancer patients undergo…
-
FDA approval · 2017-03-17FDA Approved: CISPLATIN — Original Application (Sagent Pharmaceuticals)
FDA approved Sagent Pharmaceuticals' original application for cisplatin, a generic injectable chemotherapy agent (ANDA approval).
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Single Subject Neratinib in Bladder Cancer (NRR)
A single-subject clinical trial of neratinib in bladder cancer has been updated and is no longer available.
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Early Postoperative Administration of Oxycodone +/- Naloxone and Duration of Epidural Analgesia [Phase 4]
Phase 4 trial update evaluating early postoperative oxycodone with or without naloxone and its effect on the duration of epidural analgesia …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-03-01Clinical Trial Update: Neutrophil-to-Lymphocyte Ratio in Bladder Cancer: A Secondary Biomarker Analysis of SWOG 8710
A secondary biomarker analysis report on neutrophil-to-lymphocyte ratio in bladder cancer using data from the SWOG 8710 trial.
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Efficacy of Combination of Trastuzumab to Gemcitabine - Platinum Advanced or Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 trial update evaluating the combination of trastuzumab with gemcitabine and platinum chemotherapy in patients with advanced or metas…
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer [EARLY_Phase 1]
The PRIME pilot study evaluating percutaneous BCG vaccination for bladder cancer has completed its EARLY Phase 1 trial.
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Feasibility of Online Adaptive Radiotherapy for Muscle Invasive Bladder Cancer [NA]
This clinical trial evaluated the feasibility of online adaptive radiotherapy for muscle-invasive bladder cancer and has completed.
-
CLINICAL_TRIALS research · 2017-01-24Clinical Trial Update: The Assessment of POCD After TURBT Under Spinal Anesthesia [Phase 4]
Phase 4 clinical trial update evaluating postoperative cognitive dysfunction after transurethral resection of bladder tumor performed under …
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: High-dose ICE With Amifostine [Phase 2]
Phase 2 trial evaluating high-dose ICE chemotherapy with Amifostine has completed accrual and results are reported for multiple solid tumors…
-
FDA approval · 2017-01-19FDA Approved: CISPLATIN — Supplemental Application (WG Critical Care, LLC)
The FDA approved a supplemental application for cisplatin submitted by WG Critical Care, LLC.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Internet-based System for Cancer Patients to Self-report Toxicity [NA]
This updates on a completed clinical trial evaluating an internet-based system that allows cancer patients to self-report treatment-related …
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2) [Phase 2]
Phase 2 clinical trial update for atezolizumab in locally advanced or metastatic urothelial bladder cancer has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Acceptability of Less Harmful Alternatives to Cigarettes [NA]
This completed clinical trial posted results in 2016 evaluating the acceptability of less harmful alternatives to cigarettes across multiple…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Markers of Response to Intravesical Bladder Cancer Therapy
This entry summarizes a completed clinical trial that investigated markers of response to intravesical therapy for bladder cancer.
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. [Phase 1]
This Phase I trial evaluated vorinostat in combination with docetaxel in patients with advanced and relapsed solid malignancies, including n…
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: 1B Intravesical Administration of SCH 721015 (Ad-IFNa) in Admixture With SCH 209702 (Syn3) for The Treatment of BCG Refractory Superficial Bladder Cancer [Phase 1]
A Phase 1 clinical trial evaluating intravesical Ad-IFNa (SCH 721015) in admixture with Syn3 (SCH 209702) for BCG-refractory superficial bla…
-
CLINICAL_TRIALS research · 2016-11-17Clinical Trial Update: Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients [Phase 2]
Phase 2 clinical trial evaluating prophylactic intravesical chemotherapy to prevent bladder recurrence after nephroureterectomy for primary …
-
FDA approval · 2016-11-17FDA Approved: GEMCITABINE — Supplemental Application (Hospira, Inc.)
FDA approved Hospira, Inc.'s supplemental application for gemcitabine under ANDA 079183. This represents approval of a supplemental submissi…
-
CLINICAL_TRIALS trial_result · 2016-11-09Clinical Trial Update: Bladder Cancer Patient-Reported Outcomes
This clinical trial update summarizes patient-reported outcomes from a completed bladder cancer study sponsored by Baylor College of Medicin…
-
CLINICAL_TRIALS withdrawal · 2016-11-09Clinical Trial Update: Urinary Diversion During Robotic Assisted Radical Cystectomy in Patients With Bladder Cancer [NA]
A clinical trial evaluating urinary diversion during robotic-assisted radical cystectomy for bladder cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Comparing Rectus Sheath Catheter to Epidural Post Cystectomy [NA]
A clinical trial comparing rectus sheath catheter analgesia to epidural analgesia after cystectomy for bladder cancer; current status is unk…
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma [Phase 2]
Phase 2 trial evaluating gemcitabine, carboplatin, and sorafenib in chemotherapy-naive patients with advanced/metastatic bladder cancer has …
-
CLINICAL_TRIALS trial_result · 2016-11-01Clinical Trial Update: Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer [NA]
A completed clinical trial evaluating whether a low-fiber or high-fiber diet reduces bowel-related side effects in patients undergoing radia…